Abiomed reported $73.49M in Pre-Tax Profit for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Abbott ABT:US $ 2469M 317M
Abiomed ABMD:US $ 73.49M 7.24M
Atricure ATRC:US $ -16.89M 4.42M
Boston Scientific BSX:US $ 665M 93M
Cardiovascular Systems CSII:US $ -2.59M 2.6M
Globus Medical GMED:US $ 62.76M 6.75M
Inogen INGN:US $ -2.38M 2.82M
Insulet PODD:US $ 0.3M 4.2M
Johnson & Johnson JNJ:US $ 7776M 515M
Merit Medical Systems MMSI:US $ 43.88M 6.37M
Sientra SIEN:US $ -54.69M 33.49M
Tandem Diabetes Care TNDM:US $ -5.16M 22.2M
Terumo 4543:JP Y 36020M 13888M
Zimmer Biomet Holdings Inc ZBH:US $ 480.5M 53.3M